Aratana Therapeutics, Inc., a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats and dogs, provided an overview of advances for dogs in osteoarthritis and post-operative pain management at the 2015 International Veterinary Emergency & Critical Care Symposium (IVECCS) in Washington, D.C. on September 18-22.
Additionally, Aratana hosted a breakfast symposia session at the conference with Drs. Tammy Grubb and Duncan Lascalles to discuss these new advances with more than 200 emergency and critical care veterinarians. Dr. Charles E. Short moderated the session, which focused on next generation treatment options for pain and inflammation associated with osteoarthritis, along with the move toward long-acting post-operative analgesia.
Left to right: Drs. Duncan Lascelles, Tamara Grubb and Charles Short after the breakfast symposia session.
Tamara Grubb, DVM, PhD, DACVAA discussed the use of non-opioid, non-COX inhibitor in treating osteoarthritis pain with grapiprant tablets, an EP4 prostaglandin receptor antagonist (EP4 PRA) in development for dogs. Dr. Grubb is a board-certified veterinary anesthesiologist and she has a strong clinical interest and research focus in pain management, for companion animals both large and small. She is currently an assistant clinical professor of anesthesia and analgesia at Washington State University’s College of Veterinary Medicine. Dr. Grubb is also a certified veterinary acupuncturist and a consultant in a private small animal veterinary practice.
Duncan Lascelles, BVSc, PhD presented on a new treatment option for post-operative pain with long-acting bupivacaine liposome injectable suspension, a non-steroidal anti-inflammatory agent. Dr. Lascelles is currently Professor in Small Animal Surgery and Pain Management at North Carolina State University with active clinical and research interests in acute and chronic pain. At NC State University College of Veterinary Medicine, he organizes the Integrated Pain Management Service, runs the Comparative Pain Research Laboratory and is Associate Director of the Center for Comparative Medicine and Translational Research. He is board-certified in small animal surgery by the Royal College of Veterinary Surgeons, the European College of Veterinary Surgeons, and the American College of Veterinary Surgeons. The goal of his research is to improve pain control in companion animals, and facilitate analgesic development in human medicine, including pre-emptive analgesia, opioid use in cats, perioperative oxegenase inhibiting NSAIDs, outcome measures in canine osteoarthritis and feline degenerative joint disease.
Charles E. Short, DVM, MS, PhD, DACVA, DECVA, moderator of the breakfast symposium session, is the Chair of the Board of Directors of the IVAPM Research and Scholarship Foundation and works with organizations worldwide to provide information on small animal anesthesia and pain management. Dr. Short is recognized globally for his efforts in pain management has provided lectures on anesthesiology and pain management in over 40 countries.
“We were excited to share updates in pain management to the nearly 2,700 emergency and critical care veterinarians at IVECCS this year,” stated Steven St. Peter, M.D., President and Chief Executive Officer. “We will continue to provide updates across our pipeline at upcoming meetings as we bring the best in human medicine to veterinarians.”
Check back for updates from Veterinary Cancer Society (October 15-18) and American College of Veterinary Surgeons (October 21-24).